Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

McKesson logo
McKessonMCK
$292M-1.7%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$1.5M-16.7%
Viatris logo
ViatrisVTRS
$115.3M+3.3%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$1.27M+10.4%
AMP
Amphastar PharmaceuticalsAMPH
$8.8M+11.7%
ALN
Alnylam PharmaceuticalsALNY
$45.93M-0.4%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.79B+116%
Enterprise value$8.24B+72.2%
P/E36.8×-756×
P/S1.9×+0.9×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×—
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026.

Filed
Feb 26, 2026, 7:00 PM EST
Fiscal year
FY2025
Accession
0001723128-26-000011
Operating leasesDecember 31, 2025December 31, 2024
Operating lease liabilities - related party (1)14,1959,391
Current portion of operating lease liabilities8,6689,435
Current portion of operating lease liabilities - related party (1)2,7053,396
Total operating lease liabilities$58,801$47,036
Financing leases
Financing lease right of use assets$53,328$56,433
Financing lease liabilities$54,927$56,889
Current portion of financing lease liabilities3,4423,211

Item 16. Form 10-K Summary

FAQ

What is Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
Amneal Pharmaceuticals, Inc. (AMRX) reported operating lease liabilities (current) of $58.8M in Q4 2025.
How has Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 25.0% year-over-year, from $47.04M to $58.8M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) has grown at a -1.2% compound annual growth rate (CAGR), from $62.53M to $58.8M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude